Fetal blood flow velocity waveforms in relation to changing peripheral vascular resistance.

Contains fulltext : 86673.pdf (publisher's version ) (Open Access)In an acute experiment in Texel ewes, Doppler flow velocity waveforms from the fetal descending aorta were related to peripheral vascular resistance as calculated from perfusion pressure divided by electromagnetically measured volume flow in the descending aorta. Vascular resistance was increased by stepwise embolization of the peripheral circulation via repeated bolus administration of Sephadex G-25 microspheres. A rise in peripheral vascular resistance was associated with a reduction in peak and end-diastolic flow velocity and an increase in Pulsatility Index. Clinically, if similar changes are observed in growth retarded fetuses, the findings are usually interpreted to represent 'uteroplacental insufficiency'. Present data provide direct evidence that raised peripheral vascular resistance does indeed produce such waveform changes.1 maart 198

Comparative study on the properties of saturated phosphatidylethanolamine and phosphatidylcholine bilayers : Barrier characteristics and susceptibility to phospholipase A2 degradation

Comparative studies on bilayer systems of saturated phosphatidylcholines and phosphatidylethanolamines revealed a maximum in ionic permeability in phosphatidylcholine bilayers at the temperature of the gel to liquid-crystalline phase transition but such an increase in permeability was not detectable in bilayers of phosphatidylethanolamine. Furthermore, it was found that at the phase transition temperature the phosphatidylcholine bilayers are subject to rapid hydrolysis by pancreatic phospholipase A2 whereas phosphatidylethanolamine bilayers are not. These differences are discussed in view of detailed information on the molecular organization in the gel and liquid crystalline phases of the two phospholipid classes

Barrier characteristics of membrane model systems containing unsaturated phosphatidylethanolamines

The barrier characteristics of membrane model systems containing unsaturated phosphatidylethanolamines have been investigated. (1) At increasing temperatures 18:Ic/18:1c-phosphatidylethanolamine liposomes lose their permeability barrier for K+ as a consequence of the transition from a lamellar to a hexagonal orientation as detected by 31P-NMR and freeze-fracturing electron microscopy. (2) Introduction of 18:1c/18:1c-phosphatidylcholine in the 18:1c/18:1c-phosphatidylethanolamine lipid system stabilizes the bilayer structure and the permeability barrier for K+ and glucose while cholesterol destabilizes. (3) Upon heating of the investigated 18:1c/18:1c-phosphatidylcholine-18:1c/18:1c-phosphatidylethanolamine-(cholesterol) mixtures, structures are formed which give rise to isotropic 31P-NMR signals and which on the basis of freeze-fracture pictures are interpreted as sponge-like structures. Lowering the temperature results in restoration of the barrier function of the lipid structures

The occurrence of lipidic particles in lipid bilayers as seen by 31P NMR and freeze-fracture electron-microscopy

A new type of lipid organization is observed in mixtures of phosphatidylcholine with cardiolipin (in the presence of Ca2+), monoglucosyldiglyceride and phosphatidylethanolamine (in the presence of cholesterol). This phase is characterised by an isotropic 31P NMR signal and is visualised by freeze-fracturing as particles and pits on the fracture faces of the lipid bilayer. As the most favourable model for this phase we propose the inverted micelle sandwiched in between the two monolayers of the lipid bilayer

Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths worldwide due to high recurrence rates after curative treatment and being frequently diagnosed at an advanced stage. Immune-checkpoint inhibition (ICPI) has yielded impressive clinical successes in a variety of solid cancers, however results in treatment of HCC have been modest. Vaccination could be a promising treatment to synergize with ICPI and enhance response rates. Cancer testis antigens (CTAs) were recently discovered to be widely expressed in HCC and expression in macroscopically tumor-free tissues correlated with recurrence, implying the presence of micro-satellites. To determine whether CTAs are immunogenic in HCC patients, we analyzed systemic T-cell and humoral responses against seven CTAs in 38 HCC patients using a multitude of techniques; flowcytometry, ELISA and whole antigen and peptide stimulation assays. CTA-specific T-cells were detected in all (25/25) analyzed patients, of which most had a memory phenotype but did not exhibit unequivocal signs of chronic stimulation or recent antigen encounter. Proliferative CD4+ and CD8+ T-cell responses against these CTAs were found in 14/16 analyzed HCC patients. CTA-peptide stimulation-induced granzyme B, IL2, and TNFa in 8/8 analyzed patients, including two MAGEA1 peptides included based on in silico prediction. Finally, IgG responses were observed in 13/32 patients, albeit with low titers. The presence of CD4+ and CD8+ T-cells and IgG responses shows the immunogenicity of these CTAs in HCC-patients. We hypothesize that vaccines based on these tumor-specific antigens may boost preexisting CTA-specific immunity and could enhance therapeutic efficacy of ICPI in advanced HCC

TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma

Background & Aims: TIGIT is a co-inhibitory receptor, and its suitability as a target for cancer immunotherapy in HCC is unknown. PD1 blockade is clinically effective in about 20% of advanced HCC patients. Here we aim to determine whether co-blockade of TIGIT/PD1 has added value to restore functionality of HCC tumor-infiltrating T cells (TILs). Methods: Mononuclear leukocytes were isolated from tumors, paired tumor-free liver tissues (TFL) and peripheral blood of HCC patients, and used for flow cytometric phenotyping and functional assays. CD3/CD28 T-cell stimulation and antigen-specific assays were used to study the ex vivo effects of TIGIT/PD1 single or dual blockade on T-cell functions. Results: TIGIT was enriched, whereas its co-stimulatory counterpart CD226 was down-regulated on PD1high CD8+ TILs. PD1high TIGIT+ CD8+ TILs co-expressed exhaustion markers TIM3 and LAG3 and demonstrated higher TOX expression. Furthermore, this subset showed decreased capacity to produce IFN-γ and TNF-α. Expression of TIGIT-ligand CD155 was up-regulated on tumor cells compared with hepatocytes in TFL. Whereas single PD1 blockade preferentially enhanced ex vivo functions of CD8+ TILs from tumors with PD1high CD8+ TILs (high PD1 expressers), co-blockade of TIGIT and PD1 improved proliferation and cytokine production of CD8+ TILs from tumors enriched for PD1int CD8+ TILs (low PD1 expressers). Importantly, ex vivo co-blockade of TIGIT/PD1 improved proliferation, cytokine production, and cytotoxicity of CD8+ TILs compared with single PD1 blockade. Conclusions: Ex vivo, co-blockade of TIGIT/PD1 improves functionality of CD8+ TILs that do not respond to single PD1 blockade. Therefore co-blockade of TIGIT/PD1 could be a promising immune therapeutic strategy for HCC patients